Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析

MarketLineが発行した調査報告書(SWOT20MY4484)
◆英語タイトル:Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4484
◆発行会社(リサーチ会社):MarketLine
◆発行日:2020年2月
◆ページ数:49
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chugai Pharmaceutical (Chugai or ‘the company’), the Japanese subsidiary of the Roche Group, is involved in bio pharmaceutical research and development. The company offers medical products and services for the human health. It produces antibody drugs that focus on oncology, renal diseases, immunology and infectious diseases and bone and joint diseases. Chugai’s product portfolio includes Actemra (tocilizumab), Alfarol (alfacalcidol), Avastin (bevacizumab), Bonviva (ibandronate sodium hydrate), CellCept (mycophenolate mofetil), Copegus (ribavirin), Edirol (eldecalcitol), Epogin (epoetin beta), Herceptin (trastuzumab), Kytril and Mircera (epoetin beta pegol). The company operates and markets its products in Japan, Switzerland and other regions of the world. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Chugai Pharmaceutical Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Chugai Pharmaceutical Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Chugai Pharmaceutical Co., Ltd.: Company Overview
Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts
Chugai Pharmaceutical Co., Ltd.: Overview
Chugai Pharmaceutical Co., Ltd.: Key Facts
Chugai Pharmaceutical Co., Ltd.: Key Employees
Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies
Chugai Pharmaceutical Co., Ltd.: Major Products and Services
Chugai Pharmaceutical Co., Ltd.: Company History
Chugai Pharmaceutical Co., Ltd.: Management Statement
Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Chugai Pharmaceutical Co., Ltd.: Key Competitors
Chugai Pharmaceutical Co., Ltd.: Company Analysis
Chugai Pharmaceutical Co., Ltd.: Business Description
Chugai Pharmaceutical Co., Ltd.: SWOT Analysis
Chugai Pharmaceutical Co., Ltd.: SWOT Overview
Chugai Pharmaceutical Co., Ltd.: Strengths
Chugai Pharmaceutical Co., Ltd.: Weaknesses
Chugai Pharmaceutical Co., Ltd.: Opportunities
Chugai Pharmaceutical Co., Ltd.: Threats
Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity
Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview
Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Chugai Pharmaceutical Co., Ltd.: Top Deals 2016 – 2020YTD*
Chugai Pharmaceutical Co., Ltd.: Advisors
Chugai Pharmaceutical Co., Ltd.: Top Legal Advisors
Chugai Pharmaceutical Co., Ltd.: Partnership
Chugai Pharmaceutical Co., Ltd.: Divestments
Chugai Pharmaceutical Co., Ltd.: Recent Developments
Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Chugai Pharmaceutical Co., Ltd.: Business Expansion
Chugai Pharmaceutical Co., Ltd.: Contracts
Chugai Pharmaceutical Co., Ltd.: Corporate Governance
Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility
Chugai Pharmaceutical Co., Ltd.: Financial Performance
Chugai Pharmaceutical Co., Ltd.: Market Developments
Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Chugai Pharmaceutical Co., Ltd.: Research & Development
Chugai Pharmaceutical Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Chugai Pharmaceutical Co., Ltd.: Key Facts
Table 2: Chugai Pharmaceutical Co., Ltd.: Key Employees
Table 3: Chugai Pharmaceutical Co., Ltd.: Company History
Table 4: Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Table 5: Chugai Pharmaceutical Co., Ltd.: Key Competitors
Table 6: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Table 9: Chugai Pharmaceutical Co., Ltd.: Top Deals 2016 - 2020YTD*
Table 10: Chugai Pharmaceutical Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 12: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 13: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 14: Chugai Pharmaceutical Co., Ltd.: Divestments by Geography (2016 - YTD*2020)
Table 15: Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Table 16: Chugai Pharmaceutical Co., Ltd.: Business Expansion
Table 17: Chugai Pharmaceutical Co., Ltd.: Contracts
Table 18: Chugai Pharmaceutical Co., Ltd.: Corporate Governance
Table 19: Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility
Table 20: Chugai Pharmaceutical Co., Ltd.: Financial Performance
Table 21: Chugai Pharmaceutical Co., Ltd.: Market Developments
Table 22: Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Table 23: Chugai Pharmaceutical Co., Ltd.: Research & Development
Table 24: Chugai Pharmaceutical Co., Ltd.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析(Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆